International Association

WestJet and IAM reach tentative agreement

Retrieved on: 
Jeudi, mai 9, 2024

CALGARY, AB, May 9, 2024 /CNW/ - Yesterday evening, WestJet and the International Association of Machinists and Aerospace Workers (IAM), the certified union representing WestJet load controllers, reached a tentative agreement on the first collective bargaining agreement between the organizations.

Key Points: 
  • CALGARY, AB, May 9, 2024 /CNW/ - Yesterday evening, WestJet and the International Association of Machinists and Aerospace Workers (IAM), the certified union representing WestJet load controllers, reached a tentative agreement on the first collective bargaining agreement between the organizations.
  • Both parties now await the ratification vote to be put forward to membership.
  • "WestJet is pleased to have reached a tentative agreement that recognizes the important contributions of our load controllers," said Diederik Pen, President of WestJet Airlines and Group Chief Operating Officer.
  • "They play an integral role in the safety and performance of our operations and this agreement recognizes the talent, dedication and hard work of this collective group."

Cerevance Presents at IAPRD XXIX World Congress on Parkinson’s Disease and Related Disorders

Retrieved on: 
Jeudi, mai 9, 2024

BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, will present an oral presentation at the upcoming International Association of Parkinsonism and Related Disorders (IAPRD) XXIX World Congress on Parkinson’s Disease and Related Disorders, taking place in Lisbon, Portugal from May 19-22, 2024.

Key Points: 
  • BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, will present an oral presentation at the upcoming International Association of Parkinsonism and Related Disorders (IAPRD) XXIX World Congress on Parkinson’s Disease and Related Disorders, taking place in Lisbon, Portugal from May 19-22, 2024.
  • Overview: In a Phase 2 clinical trial, CVN424, a novel, non-dopaminergic, GPR6 inverse agonist, demonstrated a significant reduction in OFF time and was safe and well tolerated with low rates of mostly mild and moderate adverse events.
  • Patients also reported enhanced motor functionality in daily activities, as assessed by the UPDRS Part II.
  • These findings enhance the confidence in CVN424's potential to address both motor and non-motor symptoms of Parkinson’s disease, consistent with observations in pre-clinical models, potentially heralding a transformative non-dopaminergic therapy.

RSA Conference 2024 Announces Annual Awards for Lifetime Achievement and Excellence in the Field of Mathematics

Retrieved on: 
Mardi, mai 7, 2024

SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- RSA Conference™, the world's leading cybersecurity conferences and expositions, today announced the recipient of the RSA Conference 2024 Lifetime Achievement Award, Michael Brown, Rear Admiral, US Navy (Ret.

Key Points: 
  • SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- RSA Conference™, the world's leading cybersecurity conferences and expositions, today announced the recipient of the RSA Conference 2024 Lifetime Achievement Award, Michael Brown, Rear Admiral, US Navy (Ret.
  • For the third consecutive year, the International Association for Cryptologic Research (IACR) co-sponsored the Mathematics Award with RSA Conference.
  • The Lifetime Achievement Award honors outstanding leaders who have made significant contributions to the advancement of the cybersecurity industry over their lifetime.
  • The RSA Conference 2024 Lifetime Achievement Award is awarded to Michael Brown, Rear Admiral, US Navy (Ret.)

Discover the Unique Nature of South America & Antarctica with 2025-26 Cruise Season from Princess Cruises

Retrieved on: 
Lundi, mai 6, 2024

SANTA CLARITA, Calif., May 6, 2024 /PRNewswire/ -- The exotic nature of South America attracts travelers to experience the diverse cultures, food, biomes, and the grandeur of the last "untouched" region of Antarctica. In fact, according to the International Association of Antarctica Tour Operators (IAATO), a record 105,331 people visited Antarctica last season. With its newly announced 2025-2026 season, Princess Cruises gives more guests the opportunity to see this less traveled part of the world with affordable rates, a wide range of shore excursions, and the comfort of a ship that can safely navigate this journey while offering countless amenities and activities to enjoy.

Key Points: 
  • In fact, according to the International Association of Antarctica Tour Operators (IAATO), a record 105,331 people visited Antarctica last season.
  • "Our upcoming 2025-26 cruise season to South America and Antarctica promises remarkable journeys with incredible opportunities to glide through glacial waters of Antarctica to enjoy views of Elephant Island, Antarctic Sound and Gerlache Strait – all unforgettable sites to behold," said Terry Thornton, chief commercial officer, Princess Cruises.
  • Why book a 2025-26 South America & Antarctic adventure with Princess Cruises?
  • Additional information about Princess Cruises is available through a professional travel advisor, by calling 1-800-Princess (1-800-774-6237) or by visiting www.princess.com .

BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics

Retrieved on: 
Vendredi, mai 3, 2024

The conference call and webinar will feature presentations by Key Opinion Leaders (KOLs) Trevor M. Feinstein, M.D.

Key Points: 
  • The conference call and webinar will feature presentations by Key Opinion Leaders (KOLs) Trevor M. Feinstein, M.D.
  • (MD Anderson Cancer Center), who will discuss below topics:
    Also featured will be a management discussion on technology platform and pipeline updates of SEED Therapeutics, BeyondSpring’s majority-owned molecular glue subsidiary.
  • He joined Piedmont Cancer Institute in 2011 and is the Director of Research at Piedmont Fayette Hospital.
  • Dr. Lin runs a translational research team that evaluates biomarkers for treatment response and disease outcomes after cancer therapy.

Eating disorders symposium a groundbreaking success

Retrieved on: 
Jeudi, mai 2, 2024

PEKIN, Ill., May 2, 2024 /PRNewswire/ -- The International Association of Eating Disorder Professionals (iaedp™) 2024 Symposium marked a significant milestone, reflecting growth and renewed commitment within the field of eating disorder treatment.

Key Points: 
  • PEKIN, Ill., May 2, 2024 /PRNewswire/ -- The International Association of Eating Disorder Professionals (iaedp™) 2024 Symposium marked a significant milestone, reflecting growth and renewed commitment within the field of eating disorder treatment.
  • "We are thrilled with the turnout and the exchange of ideas and research at this year's symposium," said Bonnie Harken, managing director of iaedp.
  • The symposium featured a lineup of keynote speakers who are leading experts in psychology, nutritional science, and therapeutic practices related to eating disorders.
  • "We are already looking forward to next year's symposium in Palm Desert on February 20-23, 2024, and building on the success of this event," added Harken.

Report on Payments to Governments for 2023

Retrieved on: 
Vendredi, mai 3, 2024

Total payments below £86,000 made to a government are excluded from this report, as permitted under the UK Regulations.

Key Points: 
  • Total payments below £86,000 made to a government are excluded from this report, as permitted under the UK Regulations.
  • Production entitlements are the host government’s share of production during the reporting period from the Shaikan Field operated by Gulf Keystone.
  • Royalties represent royalties paid in-kind to governments during the year for the extraction of oil.
  • These include licence fees, rental fees, entry fees, capacity building payments, security fees and other considerations for licences or concessions.

Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety

Retrieved on: 
Lundi, avril 22, 2024

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Over the past decade, the cannabis market has undergone significant expansion, driven largely by a wave of legalization efforts across the United States and other parts of the world. As state and national governments reassess their legal stance on cannabis, both for medical and recreational use, the industry has seen a surge in legitimacy and economic interest. In the United States, a majority of states have legalized cannabis in some form, reflecting a shift in public opinion and an acknowledgement of the potential medical benefits and revenue generation opportunities. Globally, countries like Canada, Uruguay, and several European nations have moved towards more liberal cannabis policies, further propelling the market's growth. The financial implications of these legalization efforts are substantial and continue to evolve. According to a report by Grand View Research, the global legal cannabis market size was valued at USD 13.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 25.5% from 2022 to 2030. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Cronos Group Inc. (NASDAQ: CRON), Canopy Growth Corporation (NASDAQ: CGC), Aurora Cannabis Inc. (NASDAQ: ACB), Curaleaf Holdings, Inc. (OTC: CURLF)

Key Points: 
  • Globally, countries like Canada, Uruguay, and several European nations have moved towards more liberal cannabis policies, further propelling the market's growth.
  • One of the primary concerns is the correlation between cannabis use and impaired driving.
  • Studies have shown that cannabis can significantly impair motor coordination, reaction times, and decision making, which are critical skills for safe driving.
  • NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California

Retrieved on: 
Lundi, avril 22, 2024

VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April.

Key Points: 
  • VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April.
  • Cannabix’s Dr. Bruce Goldberger Ph.D., will be presenting on Science & Technology Behind Cannabis Breath Testing and the Company’s marijuana breathalyzer system at the conference workshop session.
  • IACT is composed of governmental agency personnel involved in chemical testing related to traffic safety.
  • IACT has standing committees to address various areas including legislation, training, new equipment and procedures and manufacturers of breath testing equipment.

Exterro Donates Award-Winning Digital Forensics Solution to Empower 2024 IACIS Training Event

Retrieved on: 
Lundi, avril 22, 2024

For more than a quarter of a century IACIS has provided state-of-the-art computer forensic training to students around the world.

Key Points: 
  • For more than a quarter of a century IACIS has provided state-of-the-art computer forensic training to students around the world.
  • The donation signals Exterro’s long-term commitment to the digital forensics industry and its mission of helping investigators close cases more quickly.
  • IACIS is dedicated to the training and certification of the digital forensics community by providing law enforcement focused membership services, training, and certification.
  • The 2024 IACIS Training Event is being held in Orlando, Florida, from April 22 through May 3, 2024.